ArticleEJNMMI research2016

The use of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) as a pathway-specific biomarker with AZD8186, a PI3Kβ/δ inhibitor.

Juliana Maynard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.